1-9 of 9
Bazetta Blacklock Schuver
Close
Sort by
Journal Articles

Alemtuzumab-Cyclosporine Versus Tacrolimus-Methotrexate-Sirolimus for Graft-Versus-Host Disease Prophylaxis in Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors: Final Results of a Randomized Trial

Lauren M. Curtis, MD, Steven Z. Pavletic, MD, Rachel B. Salit, MD, Brian C Shaffer, MD, Seth M. Steinberg, PhD, Jennifer S. Wilder, RN, Filip Pirsl, Bazetta Blacklock-Schuver, RN, Jennifer Hsu, RN, Thomas E. Hughes, PharmD, David Stroncek, MD, Sharon Adams, Jennifer Hendricks, LCSW-C, Daniele N. Avila, CRNP, Jennifer Mann, CRNP, David C. Halverson, MD, Thea M. Friedman, PhD, Robert Korngold, PhD, Juan C. Gea-Banacloche, MD, Daniel H. Fowler, MD, Dennis L. Confer, MD, Frances T. Hakim, PhD, Ronald E. Gress, MD, Michael R. Bishop, MD
Journal: Blood
Blood (2015) 126 (23): 65.
https://doi.org/10.1182/blood.V126.23.65.65
Published: 2015
Journal Articles

Pilot Study of Radiation-Targeted Donor Lymphocyte Infusion for Cancer Progression after Allogeneic Hematopoietic Stem Cell Transplantation

Nancy M. Hardy, MD, Deborah Citrin, MD, Frances T. Hakim, PhD, Daniele N. Avila, CRNP, Bazetta Blacklock-Schuver, RN, Stephanie Cotton, RN, Monica Cho, Daniel H. Fowler, MD, Juan C. Gea-Banacloche, MD, Noa G. Holtzman, MD, Karen A. Kurdziel, MD, Sarfraz Memon, MD, Steven Z. Pavletic, MD, Stefania Pittaluga, MD PhD, Jeremy J. Rose, BA, Claude Sportes, MD, Jennifer S. Wilder, RN, Ronald E. Gress, MD, Michael R. Bishop, MD
Journal: Blood
Blood (2015) 126 (23): 1962.
https://doi.org/10.1182/blood.V126.23.1962.1962
Published: 2015
Journal Articles

FLT Imaging Reveals Kinetics and Biology of Engraftment after Myeloablative HSCT

Kirsten M Williams, MD, Jennifer L. Holter Chakrabarty, MD, Liza Lindenberg, MD, Steve Adler, Juan Gea-Banacloche, MD, Bazetta Blacklock-Schuver, RN, Frances T. Hakim, PhD, Dennis D. Hickstein, MD, James N Kochenderfer, MD, Jennifer Wilder, Tracey Chinn, RN, Karen Kurdziel, MD, Seth M. Steinberg, PhD, Hanh Khuu, Frank I Lin, Daniel H. Fowler, MD, David Halverson, MD, Daniele N. Avila, CRNP, George Selby, MD, Tiffani N. Taylor, PA, Jennifer Mann, Jennifer Hsu, RN, Robert B. Epstein, MD, Stacy L Anderson, Nguyen Chuong, Joseph Havlicek, Shibo Li, MD, Tom Pham, Teresa Kraus, Sara K. Vesely, PhD MPH, Steven Z. Pavletic, MD, Catherine M. Bollard, MBChB, MD, Peter Choyke, MD, Ronald E Gress, MD
Journal: Blood
Blood (2014) 124 (21): 1147.
https://doi.org/10.1182/blood.V124.21.1147.1147
Published: 2014
Journal Articles

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation

James N. Kochenderfer, Mark E. Dudley, Robert O. Carpenter, Sadik H. Kassim, Jeremy J. Rose, William G. Telford, Frances T. Hakim, David C. Halverson, Daniel H. Fowler, Nancy M. Hardy, Anthony R. Mato, Dennis D. Hickstein, Juan C. Gea-Banacloche, Steven Z. Pavletic, Claude Sportes, Irina Maric, Steven A. Feldman, Brenna G. Hansen, Jennifer S. Wilder, Bazetta Blacklock-Schuver, Bipulendu Jena, Michael R. Bishop, Ronald E. Gress, Steven A. Rosenberg
Journal: Blood
Blood (2013) 122 (25): 4129–4139.
https://doi.org/10.1182/blood-2013-08-519413
Published: 2013
Includes: Supplemental data
Journal Articles

Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation

James N Kochenderfer, M.D., Mark E. Dudley, Ph.D., Robert O. Carpenter, Sadik H Kassim, Ph.D., Jeremy J. Rose, William Telford, Ph.D., Frances T Hakim, PhD, David Halverson, MD, Daniel H. Fowler, MD, Nancy M. Hardy, MD, Anthony Mato, Dennis D. Hickstein, M.D., Juan Gea-Banacloche, MD, Steven Z. Pavletic, MD, Claude Sportes, MD, Irina Maric, MD, Steven Feldman, Ph.D., Brenna G Hansen, RN, Jennifer Wilder, RN, Bazetta Blacklock-Schuver, RN, Bipulendu Jena, PhD, Michael Bishop, MD, Steven A. Rosenberg, M.D., Ph.D., Ronald E. Gress, MD
Journal: Blood
Blood (2013) 122 (21): 151.
https://doi.org/10.1182/blood.V122.21.151.151
Published: 2013
Journal Articles

Pre-Emptive T-Rapa Cell DLI for Therapy of High-Risk Lymphoma After Low-Intensity Allogeneic HCT

David Halverson, MD, Miriam E. Mossoba, PhD, Seth M. Steinberg, PhD, Bazetta blacklock-Schuver, Frances T. Hakim, PhD, Roger Kurlander, MD, Juan Gea-Banacloche, MD, Claude Sportes, MD, Nancy M. Hardy, MD, Dennis D. Hickstein, M.D., Steven Z. Pavletic, MD, Hanh Khuu, MD, Marianna Sabatino, MD, David Stroncek, MD, Susan F. Leitman, MD, Scott D. Rowley, MD, Michele L. Donato, MD, Andre Goy, MD, Robert Korngold, PhD, Andrew L. Pecora, MD, Bruce L. Levine, PhD, Carl H. June, MD, Michael R. Bishop, MD, Carol Carini, Tatyana Feldman, MD, Anthony R. Mato, MD, Ronald E. Gress, MD, Daniel H. Fowler, MD
Journal: Blood
Blood (2012) 120 (21): 471.
https://doi.org/10.1182/blood.V120.21.471.471
Published: 2012
Journal Articles

Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation

Brief Report
Nancy M. Hardy, Vicki Fellowes, Jeremy J. Rose, Jeanne Odom, Stefania Pittaluga, Seth M. Steinberg, Bazetta Blacklock-Schuver, Daniele N. Avila, Sarfraz Memon, Roger J. Kurlander, Hahn M. Khuu, Maryalice Stetler-Stevenson, Esther Mena, Andrew J. Dwyer, Bruce L. Levine, Carl H. June, Ran Reshef, Robert H. Vonderheide, Ronald E. Gress, Daniel H. Fowler, Frances T. Hakim, Michael R. Bishop
Journal: Blood
Blood (2012) 119 (12): 2956–2959.
https://doi.org/10.1182/blood-2011-09-378398
Published: 2012
Includes: Supplemental data
Journal Articles

Concurrent Fludarabine and Cyclophosphamide As a Reduced Intensity Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation Ablates Host T-Cells and Results in Rapid Full Donor Chimerism

Rachel B. Salit, MD, Michael R. Bishop, MD, Steven Z. Pavletic, MD, Frances T. Hakim, PhD, Seth M. Steinberg, PhD, Jeanne Odom, RN, Kelly Bryant, RN, Jennifer Wilder, RN, Daniele N. Avila, CRNP, Bazetta Blacklock-Schuver, RN, Ronald E. Gress, MD, Daniel H. Fowler, MD
Journal: Blood
Blood (2011) 118 (21): 1937.
https://doi.org/10.1182/blood.V118.21.1937.1937
Published: 2011
Journal Articles

Adoptive Transfer of Treg-Depleted Donor Th1 and Th2 Cells Safely Accelerates Alloengraftment After Low-Intensity Chemotherapy

Daniel H. Fowler, MD, Miriam E. Mossoba, Ph.D., Bazetta Blacklock Schuver, Paula Layton, BSN, Frances T Hakim, PhD, Roger Kurlander, MD, Juan Gea-Banacloche, Claude Sportes, Nancy M. Hardy, MD, Steven Z. Pavletic, MD, Seth M. Steinberg, Hanh Khuu, Marianna Sabatino, MD, David Stroncek, MD, Susan Leitman, MD, Scott D Rowley, Michele L Donato, Andre Goy, MD, Thea Friedman, PhD, Robert Korngold, PhD, Andrew L Pecora, Bruce L Levine, PhD, Carl H. June, MD, Ronald E. Gress, MD, Michael R. Bishop, MD
Journal: Blood
Blood (2010) 116 (21): 521.
https://doi.org/10.1182/blood.V116.21.521.521
Published: 2010